Daisuke Nakano Selected Research

Daisuke Nakano Research Topics

Disease

29	Hypertension (High Blood Pressure) 01/2021 - 09/2002
18	Neoplasms (Cancer) 01/2022 - 05/2010
14	Insulin Resistance 01/2021 - 09/2009
13	Fibrosis (Cirrhosis) 02/2021 - 09/2009
11	Stomach Neoplasms (Stomach Cancer) 01/2022 - 11/2008
10	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022 - 05/2010
9	Hypoxia (Hypoxemia) 06/2021 - 10/2005
9	Albuminuria 01/2020 - 11/2010
8	Obesity 11/2021 - 12/2012
8	Neoplasm Metastasis (Metastasis) 09/2021 - 11/2008
7	Glucose Intolerance 01/2022 - 01/2010
7	Inflammation (Inflammations) 11/2021 - 05/2010
6	Body Weight (Weight, Body) 01/2022 - 07/2010
6	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 12/2021 - 07/2011
6	Diabetic Nephropathies (Diabetic Nephropathy) 01/2019 - 11/2008
5	Hyperglycemia 11/2021 - 07/2016
5	Chronic Renal Insufficiency 06/2021 - 09/2017
5	Anemia 06/2021 - 09/2017
5	Proteinuria 03/2020 - 09/2009
4	Hemorrhage 04/2022 - 01/2018
4	Type 2 Diabetes Mellitus (MODY) 11/2021 - 02/2011
4	Colorectal Neoplasms (Colorectal Cancer) 01/2019 - 11/2009
3	Fistula 04/2022 - 11/2008
3	Wounds and Injuries (Trauma) 01/2022 - 09/2009
3	Dyslipidemias (Dyslipidemia) 01/2022 - 12/2012
3	Reperfusion Injury 01/2021 - 04/2014
3	Ischemia 01/2021 - 04/2014
3	Glycosuria 07/2020 - 06/2018
3	Vascular Remodeling 01/2014 - 10/2011
3	Hypertrophy 02/2012 - 04/2011
3	Carcinoma (Carcinomatosis) 05/2010 - 11/2008
2	Dehydration (Water Stress) 11/2021 - 12/2020
2	Ovarian Neoplasms (Ovarian Cancer) 09/2021 - 01/2017
2	Osteosarcoma (Osteogenic Sarcoma) 09/2021 - 01/2017
2	Kidney Diseases (Kidney Disease) 12/2020 - 07/2016
2	Adenocarcinoma 01/2020 - 03/2015
2	Oliguria 01/2020 - 01/2018

Drug/Important Bio-Agent (IBA)

20	SaltsIBA 01/2022 - 12/2003
18	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2011
12	Angiotensin IIIBA 11/2018 - 09/2009
10	Messenger RNA (mRNA)IBA 11/2021 - 09/2009
9	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2009
9	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2022 - 04/2012
9	olmesartanIBA 01/2018 - 12/2007
8	AldosteroneIBA 01/2022 - 09/2009
8	SodiumIBA 01/2022 - 01/2013
8	Sodium-Glucose Transporter 2 InhibitorsIBA 11/2021 - 05/2016
8	ReninIBA 01/2020 - 09/2009
8	Insulin (Novolin)FDA Link 01/2020 - 02/2011
6	Angiotensin Receptor AntagonistsIBA 01/2022 - 06/2006
5	Erythropoietin FDA Link 12/2020 - 02/2016
5	Eplerenone (Inspra)FDA LinkGeneric 03/2012 - 09/2009
4	Sulfides (Thioethers)IBA 09/2021 - 01/2012
4	Adenine FDA LinkGeneric 12/2020 - 09/2017
4	Hydralazine (Apresoline)FDA LinkGeneric 03/2020 - 12/2003
4	Prorenin ReceptorIBA 01/2020 - 01/2010
4	Desoxycorticosterone Acetate (DOCA)FDA Link 03/2008 - 12/2003
3	Urea (Carbamide)FDA LinkGeneric 01/2022 - 07/2020
3	Spironolactone (Aldactone)FDA LinkGeneric 01/2022 - 11/2013
3	LignansIBA 12/2021 - 09/2002
3	Blood Glucose (Blood Sugar)IBA 11/2021 - 02/2011
3	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 06/2021 - 02/2016
3	esaxerenoneIBA 02/2021 - 01/2019
3	CreatinineIBA 12/2020 - 01/2018
3	1,5- anhydro- 1- (5- (4- ethoxybenzyl)- 2- methoxy- 4- methylphenyl)- 1- thioglucitolIBA 07/2020 - 04/2017
3	CateninsIBA 01/2020 - 03/2015
3	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 01/2019 - 02/2012
3	Glucagon-Like Peptide 1 (GLP 1)IBA 10/2018 - 04/2012
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018 - 06/2006
3	AntioxidantsIBA 01/2018 - 10/2011
3	FructoseIBA 11/2013 - 09/2009
3	NADPH Oxidases (NAD(P)H oxidase)IBA 08/2013 - 12/2006
3	sesaminIBA 03/2008 - 09/2002
2	Mineralocorticoid Receptor AntagonistsIBA 01/2022 - 03/2010
2	Pharmaceutical PreparationsIBA 01/2022 - 01/2021
2	Drinking WaterIBA 01/2022 - 09/2009
2	Triglycerides (Triacylglycerol)IBA 01/2022 - 01/2018
2	molidustatIBA 06/2021 - 12/2020
2	NitrogenIBA 12/2020 - 07/2020
2	Valsartan (Vals)FDA Link 03/2020 - 01/2012
2	Peptides (Polypeptides)IBA 01/2020 - 02/2009
2	LipopolysaccharidesIBA 01/2020 - 01/2018
2	Oxidants (Oxidizing Agents)IBA 01/2020 - 01/2018
2	Sodium-Glucose Transport ProteinsIBA 01/2020 - 01/2018
2	Glucagon-Like Peptide-1 ReceptorIBA 01/2020 - 10/2018
2	DesminIBA 01/2019 - 11/2010
2	NPHS2 proteinIBA 01/2019 - 03/2010
2	nephrinIBA 01/2019 - 03/2010
2	Antihypertensive Agents (Antihypertensives)IBA 01/2019 - 12/2003
2	Chymases (Chymase)IBA 11/2018 - 09/2009

Therapy/Procedure

14	Therapeutics 09/2021 - 12/2003
9	Drug Therapy (Chemotherapy) 12/2012 - 11/2008
6	Gastrectomy 12/2020 - 11/2010
4	Oral Administration 06/2018 - 04/2007
3	Neoadjuvant Therapy 11/2010 - 06/2009
2	Surgical Instruments (Clip) 04/2022 - 02/2022
2	Nephrectomy 06/2021 - 01/2021
2	Caloric Restriction 01/2021 - 01/2020
2	Denervation 01/2020 - 03/2012
2	Resuscitation 01/2020 - 12/2015